ELUT Stock Analysis: Buy, Sell, or Hold?
ELUT - Elutia Inc. Class A Common Stock
$1.01
0.01 (1.12%)
▲
5d:
+0.0%
30d:
-10.62%
90d:
+2.32%
HOLD
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 14, 2026
5d
Get Alerted When ELUT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ELUT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ELUT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ELUT is currently trading at $1.01, which is considered oversold relative to its 30-day fair value range of $1.02 to $1.15.
Technical Outlook: Technically, ELUT is in a strong uptrend. Immediate support is located at $0.95, while resistance sits at $1.10.
Market Sentiment: ELUT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+395.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ELUT is in a strong uptrend. Immediate support is located at $0.95, while resistance sits at $1.10.
Market Sentiment: ELUT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+395.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.02 -
$1.15
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 395.0% below Wall St target ($5.00)
Trading Range Analysis
30-Day Trading Range
$1.02 -
$1.15
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.95
Resistance Level
$1.10
Current Trend
Strong Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.98
Wall Street Target
$5.00
(+395.0%)
Revenue Growth (YoY)
16.2%
Profit Margin
434.2%
Share & Embed Analysis
Last updated: May 08, 2026 6:57 PM ET
Data refreshes hourly during market hours. Next update: 7:57 PM
Data refreshes hourly during market hours. Next update: 7:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELUT showing a specific setup today?
Insider Activity (6 Months)
13
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Guido J Neels
BUY
20000 shares
2026-01-30
Kevin Rakin
BUY
70000 shares
2026-01-30
Guido J Neels
BUY
15000 shares
2026-01-28
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$394 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 56 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 56 HOLD |
